SCID mice as an in vivo model of human cord blood hematopoiesis
- PMID: 7538337
SCID mice as an in vivo model of human cord blood hematopoiesis
Abstract
Cord blood is increasingly used as an alternative stem cell source for autologous and allogeneic transplantation, particularly in pediatric patients. We therefore adopted our protocol for transplanting human adult bone marrow cells into severe combined immunodeficient (SCID) mice [1] to develop an in vivo model for cord blood hematopoiesis. Intravenous injection of unfractionated or Ficoll-separated cord blood cells into sublethally irradiated SCID mice led to high levels of human hematopoiesis in the majority of the recipients [2]. Multilineage human hematopoiesis including committed and multipotential myeloerythroid progenitors as well as CD19+ B-lymphoid cells were observed in the murine bone marrow for at least 18 weeks. Together, these data indicate that the SCID mice were engrafted with an immature cell that was able to maintain multiple progenitor lineages in vivo. In contrast to our experiences with adult bone marrow, high levels of human cell engraftment in the mouse could be achieved without exogenous cytokine treatment, suggesting that the cord blood cells respond differently to the murine microenvironment. Alternatively, the cord blood cells might have been able to provide themselves with the necessary growth factors in a paracrine fashion. This model will be useful in gaining new insights into the biology of immature human cord blood progenitors and cord blood transplantation.
Comment in
-
Commentary: Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models.Blood Cells. 1994;20(2-3):323-30. Blood Cells. 1994. PMID: 7749113
Similar articles
-
Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.Biol Blood Marrow Transplant. 1997 Nov;3(5):236-46. Biol Blood Marrow Transplant. 1997. PMID: 9450918
-
Engraftment of ex vivo expanded and cycling human cord blood hematopoietic progenitor cells in SCID mice.Exp Hematol. 1998 Jun;26(6):507-14. Exp Hematol. 1998. PMID: 9620284
-
Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.Bone Marrow Transplant. 1999 Feb;23(3):203-9. doi: 10.1038/sj.bmt.1701564. Bone Marrow Transplant. 1999. PMID: 10084250
-
The in vitro and in vivo effects of stem cell factor on human hematopoiesis.Stem Cells. 1993 Jul;11 Suppl 2:76-82. doi: 10.1002/stem.5530110813. Stem Cells. 1993. PMID: 7691331 Review.
-
Mouse models for human hematopoiesis.Semin Immunol. 1991 Nov;3(6):367-78. Semin Immunol. 1991. PMID: 1799667 Review.
Cited by
-
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Regen Med. 2011 May;6(3):367-406. doi: 10.2217/rme.11.22. Regen Med. 2011. PMID: 21548741 Free PMC article.
-
The use of BLT humanized mice to investigate the immune reconstitution of the gastrointestinal tract.J Immunol Methods. 2014 Aug;410:28-33. doi: 10.1016/j.jim.2014.06.009. Epub 2014 Jun 18. J Immunol Methods. 2014. PMID: 24952245 Free PMC article. Review.
-
Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation.F1000Res. 2019 Oct 31;8:F1000 Faculty Rev-1833. doi: 10.12688/f1000research.20002.1. eCollection 2019. F1000Res. 2019. PMID: 31723413 Free PMC article. Review.
-
Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.Stem Cells. 2009 Nov;27(11):2675-85. doi: 10.1002/stem.204. Stem Cells. 2009. PMID: 19711457 Free PMC article.
-
Status of umbilical cord blood transplantation in the year 2001.J Clin Pathol. 2001 Jun;54(6):428-34. doi: 10.1136/jcp.54.6.428. J Clin Pathol. 2001. PMID: 11376014 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases